July 22, 2014 10:27 AM ET

Biotechnology

Company Overview of Chrysalis BioTechnology, Inc.

Company Overview

Chrysalis BioTechnology, Inc., a development stage company, develops synthetic peptide compounds targeted at tissue repair and regeneration in the United States. It has four research categories focusing on Chrysalin: orthopedic tissue repair, dermal wound healing, dental bone repair, and cardiovascular research. The company's lead product, Chrysalin, is in phase III human clinical for bone fracture healing, and phase II trials for chronic diabetic ulcers. It is also developing an injectable form of Chrysalin, which is being clinically tested in fracture healing. Chrysalis BioTechnology has strategic partnership with OrthoLogic Corp. for the orthopedic applications of Chrysalin, including bon...

2200 Market Street

Suite 600

Galveston, TX 77550

United States

Founded in 1995

Phone:

409-750-9251

Fax:

409-750-9253

Key Executives for Chrysalis BioTechnology, Inc.

Chrysalis BioTechnology, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Kadmon Corporation, LLC United States
CS-Keys, Inc. United States
Aduro BioTech, Inc. United States
DEW Technologies, Inc. United States
Kellbenx Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chrysalis BioTechnology, Inc., please visit www.chrysalisbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.